Showing results (411-420 of 548) with videos related to
Sort By:
Pageof 55
Cancer Medicine|December 22, 2018
The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trialsFrederick Lansigan, Ian Barak, Brandelyn Pitcher, et al.Journal of Child Neurology|October 28, 2008
Targeting hyaluronan interactions in spinal cord astrocytomas and diffuse pontine gliomasBernard L Maria, Nalin Gupta, Anne G Gilg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Humanized anti-CD20 antibody, veltuzumab, in refractory/recurrent non-Hodgkin's lymphoma: phase I/II resultsFranck Morschhauser, John P Leonard, Luis Fayad, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2022
Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance)Ann S LaCasce, Travis Dockter, Amy S Ruppert, et al.Journal of the American Chemical Society|September 6, 2018
Insights on the Proton Insertion Mechanism in the Electrode of Hexagonal Tungsten Oxide HydrateHeng Jiang, Jessica J Hong, Xianyong Wu, et al.Cancer|December 20, 2005
Subsequent therapy can be administered after tositumomab and iodine I-131 tositumomab for non-Hodgkin lymphomaAlan D Dosik, Morton Coleman, Lale Kostakoglu, et al.Blood|January 30, 2019
A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphomaPeter Martin, Nancy L Bartlett, Kristie A Blum, et al.Revue Medicale De Liege|January 25, 2008
[New approaches to the treatment of the HIV-infected patient]K Chandrika, P Dellot, F Frippiat, et al.Cancer|November 6, 2009
Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non-Hodgkin lymphoma: results from a Multicenter StudyBrad S Kahl, Nancy L Bartlett, John P Leonard, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 2, 2010
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of follicular lymphoma: an evidence-based reviewDenise M Oliansky, Leo I Gordon, Jerry King, et al.Pageof 55